Skip to main content
CARCLO PLC logo

CARCLO PLC — Investor Relations & Filings

Ticker · CAR ISIN · GB0001751915 LEI · 21380078MEM399JPI956 IL Manufacturing
Open in API
Filings indexed 558 across all filing types
Latest filing 2018-07-03 Regulatory Filings
Country GB United Kingdom
Listing IL CAR

About CARCLO PLC

http://www.carclo-plc.com/

Carclo PLC is a global precision engineering group that designs, industrializes, and manufactures high-reliability solutions and complex components. The company specializes in fine-tolerance, injection-molded plastic parts and multi-component assemblies. Its core competencies encompass the entire production lifecycle, from initial design, engineering, and mold creation to advanced manufacturing processes like precision injection molding and automated assembly. Carclo provides comprehensive supply chain solutions, serving demanding, precision-focused markets including Life Sciences, Aerospace, Optics, and other advanced technology sectors. Key product areas include components for in-vitro diagnostics, drug delivery systems, and advanced optical systems.

Recent filings

Filing Released Lang Actions
Form 8.3 - Carclo plc
Regulatory Filings Classification · 98% confidence The document is explicitly labeled as an 'RNS Number' and contains the header 'FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' under 'Rule 8.3 of the Takeover Code'. This type of disclosure relates to insider/significant shareholder dealings during a takeover scenario. While it details director/insider transactions (similar to DIRS), the specific format (Form 8.3) and context (Takeover Code disclosure) strongly align with regulatory reporting concerning share ownership changes, which is often captured under general regulatory filings or specific insider transaction reports. Given the options, 'Director's Dealing' (DIRS) covers personal share transactions by executives, and this disclosure, while specific to a takeover context, is fundamentally a report of a significant shareholder's position and dealings. However, since it is a mandatory filing disseminated via RNS concerning interests in securities during a takeover, it fits the scope of insider/director dealing disclosures, which is the closest specific category. If DIRS is interpreted strictly as routine director trades outside of M&A, then RNS might be a fallback. But Form 8.3 is a specific type of insider disclosure. I will classify it as DIRS due to the focus on interests and dealings of a major shareholder/insider, noting the RNS dissemination.
2018-07-03 English
Form 8.3 - Carclo plc
Director's Dealing Classification · 95% confidence The document is explicitly labeled as an 'RNS Number' and contains the header 'FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' under 'Rule 8.3 of the Takeover Code'. This form relates to disclosures required during a takeover situation, which involves insider/significant shareholder dealings. The closest specific category is 'Director's Dealing' (DIRS), as it concerns personal share transactions by parties involved in a takeover/holding significant stakes. However, Form 8.3 is a specific regulatory filing related to the Takeover Code, which often falls under general regulatory announcements if a more specific category like DIRS (which usually implies Form 3, 4, or 5 under SEC rules, or similar insider transaction reports) is not a perfect fit for Takeover Code disclosures. Given the context of insider/significant shareholder dealing disclosure during a takeover, DIRS is the most appropriate fit among the provided options, as it covers personal share transactions by executives/directors (or in this case, significant holders involved in the bid). The document concludes by stating, 'This information is provided by RNS, the news service of the London Stock Exchange,' suggesting it is a regulatory announcement. Since it details specific dealings and positions related to a takeover bid, DIRS is chosen over the general RNS fallback.
2018-07-03 English
Form 8.3 - Carclo plc
Regulatory Filings Classification · 98% confidence The document is explicitly titled 'FORM 8.3' and references 'Rule 8.3 of the Takeover Code'. It details 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' concerning an offer involving 'Carclo plc' and 'Consort Medical plc'. This type of mandatory disclosure related to takeover activity and insider/significant shareholder positions is a specific regulatory filing, but it is not one of the primary SEC forms (10-K, MRQ, etc.). The document is distributed via 'RNS Number' and mentions the 'London Stock Exchange' and the 'Takeover Panel'. Given the specific nature of reporting dealings/positions during a takeover under the UK Takeover Code, and the fact that it is a regulatory announcement distributed via RNS, it fits best under the general 'Regulatory Filings' category (RNS) as a specific type of regulatory disclosure that isn't covered by the other specialized codes (like DIRS for director's dealing, or TAR for M&A activity itself, though it relates to M&A). Since RNS is defined as the fallback for miscellaneous regulatory filings, and this is a specific UK regulatory filing (Form 8.3), RNS is the most appropriate classification.
2018-07-03 English
Response to announcement from Consort Medical
M&A Activity Classification · 95% confidence The document is identified by the RNS Number (2802T) and the date (02 July 2018), indicating it is a regulatory news service announcement from the London Stock Exchange. The content discusses a response to an announcement from another company (Consort Medical plc) regarding a takeover proposal, including rejection of the indicative offer and updates on internal strategy and board appointments. This type of announcement, which is a formal disclosure of material, non-public information to the market via an official channel (RNS), fits best under the general 'Regulatory Filings' category, as it is not a specific financial report (like 10-K or IR), a management discussion (MDA), or a specific corporate action like a dividend or share buyback, but rather a market update related to potential M&A activity and governance changes, released through the RNS system. Since 'M&A Activity' (TAR) is usually for the proposal itself or definitive agreement, and this is a response/update, RNS is the most appropriate general regulatory filing code.
2018-07-02 English
Non-Binding Proposal for Carclo plc
M&A Activity Classification · 100% confidence The document is identified by the RNS Number and explicitly states it is an 'ANNOUNCEMENT FALLING UNDER RULE 2.4 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE")'. It details a non-binding proposal by Consort Medical PLC for the acquisition of Carclo plc, which is a clear indication of M&A activity. The text also mentions that a further announcement will be made as and when appropriate, and it is distributed via RNS, the news service of the London Stock Exchange. Since the core content is about a takeover proposal/bid, the most specific category is M&A Activity (TAR). Although it is an RNS announcement, the subject matter is highly specific to M&A, making TAR a better fit than the general RNS fallback.
2018-07-02 English
Board changes
Board/Management Information Classification · 99% confidence The document is an official announcement disseminated via 'RNS Number' (Regulatory News Service), which is a common channel for UK listed companies. The content explicitly announces a change in the company's board of directors: 'Board changes' and details the appointment of Joe Oatley as a Non-Executive Director. This directly corresponds to the definition of Board/Management Information (MANG). The document is short and serves as an immediate notification, not a comprehensive report.
2018-06-28 English

Browse filings by year

37 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.